Chromone derivative as a dopamine D3 receptor antagonist for its use for the treatment of autism spectrum disorder
US10028948B2 · kind B2 · utility
0Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2014 |
| Grant date | Jul 24, 2018 |
| Priority date | — |
| Expiry date | Feb 3, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention claims a chromone derivative and pharmaceutical compositions and combinations comprising a least the said derivative, which is a dopamine D3 receptor antagonist, for their use for the treatment of autism spectrum disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.